Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial
Phase of Trial: Phase IV
Latest Information Update: 21 Nov 2018
At a glance
- Drugs Dulaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms D-LIFT
- 08 Nov 2018 Planned End Date changed from 1 Dec 2019 to 1 Feb 2020.
- 08 Nov 2018 Planned primary completion date changed from 1 Aug 2019 to 1 Nov 2019.
- 08 Nov 2018 Status changed from not yet recruiting to recruiting.